About Us

Caligor Team

Caligor Team

Powered by people who care

We share your mission

The Caligor team represents a tremendous depth and diversity of expertise—from comparator drugs and global regulations to quality systems and logistics. We all share the same core focus: helping bring effective therapies and diagnostics to patients while protecting patient safety.

Our knowledge is your advantage

Our people are Caligor’s greatest asset, providing expert consultation and strategic guidance on all aspects of your comparator program. Our in-house knowledge of regulations in jurisdictions around the world enables us to anticipate and prepare for challenges early in your trial process to avoid supply disruption.

David Edwards

CEO

Mr. Edwards has broad global management experience with leading healthcare companies with a successful track record of growing businesses in the U.S., Europe and Asia. He is based at Caligor’s European headquarters in Dartford, UK. Before being appointed as CEO of Caligor in March 2017, Mr. Edwards was the East Asia Vice President for Alcon, a Novartis company and a global leader in eye care. He also served as Executive Vice President and President of Asia-Pacific and Japan at Bausch & Lomb, and spent more than a decade in executive management positions at Johnson & Johnson. He was President of Johnson & Johnson’s diabetes business unit in Europe, the Middle East and Africa, led the Johnson & Johnson Vision Care business in the Asia-Pacific region and headed Johnson & Johnson’s Consumer Nutritionals business in Europe. Prior to joining Johnson & Johnson, Mr. Edwards spent 10 years with Nestle including Global Franchise leadership positions at their world headquarters in Vevey, Switzerland. Mr. Edwards earned an MBA from the Thunderbird School of Global Management and a bachelor’s degree in business from Gonzaga University.

Tammy Bishop

Tammy Bishop

CCO

Ms. Bishop has more than 20 years of marketing experience in the pharmaceutical industry. Most recently, she was vice president of business development for clinical trial supplies and named patient programs at Pharmarama. Prior to joining Pharmarama, Tammy served as vice president of business development and marketing for IDIS Pharmaceuticals. She has also worked as a marketing/communications consultant for Fleishman-Hillard, Metaphore Pharmaceuticals, and David Eng Communications, and has held senior corporate communications positions at OXiGENE, Gemini Genomics and Indevus Pharmaceuticals. She earned an MBA from Simmons College.

Alex Shvartsburg

Alex Shvartsburg

Chief Financial and Chief Operating Officer

Mr. Shvartsburg has been named Caligor Rx Chief Financial and Chief Operating Officer. He brings more than 20 years of life sciences industry experience in leadership roles with some of the world’s preeminent multinational organizations. During his career, he has demonstrated significant expertise and leadership in high-growth and turnaround management situations. Most recently, he served as Vice President of Finance – Genetic, Medical and Applied Sciences Division (GSD) at Thermo Fisher Scientific, overseeing global financial operations for GSD. Prior to this role, he served as head of Life Technologies Corporate Development Finance Group, playing a key role in numerous M&A transactions, including enabling a $15.8 billion acquisition of the company by Thermo Fisher Scientific. Mr. Shvartsburg began his career with Johnson and Johnson, progressing in roles of increasing responsibility. His experience with J&J includes domestic and international assignments, supporting Pharmaceutical, Medical Device and Consumer operating units. Mr. Shvartsburg earned a Bachelor of Science degree in Accounting from Drexel University and a Master of Business Administration from LaSalle University. He is a Certified Management Accountant (CMA).

Phil Joyce

Phil Joyce

Director of Operations

Mr. Joyce is responsible for the receipt, storage and distribution of medicinal products throughout Europe. He has over 25 years’ experience in the pharmaceutical industry with experience in commercial and clinical manufacturing, packaging and distribution, and wholesaling. Phil has worked for Boots The Chemist, GSK, Pfizer and Pharmarama in various roles in pharmacy, production and supply chain management, business development, and quality assurance. He holds a first class honours BSc in Pharmaceutical Sciences from Greenwich University.

victoria_parkinson_11_14_headshot_218

Victoria Parkinson

Head of Global Clinical Trial Supply

Ms. Parkinson directly manages and develops key customer accounts, providing full project management and strategic sourcing support to stage I, II, and III clinical trials. Prior to joining Caligor in 2012, Victoria served as a Senior Comparator Sourcing Specialist for a European clinical trial supplier. She has extensive experience in cold-chain and temperate shipments worldwide and more than eight years experience in customer relationship management. She has Level 4 Supply Chain Management training and a membership in the Chartered Institute of Purchasing and Supply.

stephanie_chapman_headshot

Stephanie Chapman

Global Clinical Trial Supply Manager

Ms. Chapman is charged with strategically supporting key customer activity while identifying and driving the growth and development of existing client and supplier accounts. She is responsible for handling key clinical trial accounts within the company from inception through to order fulfillment and delivery. Her previous experience includes account and project management within an international comparator sourcing company, where her role was to successfully source, supply and deliver comparator products to achieve sales growth and exceed customer needs and expectations. In addition, she played an active role in business development in order to maintain and develop business relationships with key clients. Ms. Chapman graduated from the University of Birmingham with a BSc Honors degree, having specialized in Immunology. Prior to pursuing a career in the pharmaceutical industry, Ms Chapman also attained an LLB Honors degree in Law.

kelly_fearn_headshot_218

Kelly Fearn

Vice President of Regulatory Affairs

As the Vice President of Regulatory Affairs, Ms. Fearn is responsible for leading all key regulatory aspects of Global Access Programs at Caligor. She brings with her 16 years of regulatory affairs experience in the pharmaceutical and CRO industry focusing on regulatory affairs project management and country regulatory intelligence for multinational clinical trials and global expanded access programs. Prior to joining Caligor, Kelly held numerous industry roles, including Director of Global Regulatory Affairs at I3 Research, Associate Director at Orion Clinical Services, as well as roles within Parexel and J & J Ortho Clinical Diagnostics. Most recently, she was Senior Manager of Global Regulatory Information at Idis and was responsible for country specific expanded access intelligence, regulatory training and was the subject matter expert for all external stakeholder’s as well as internal functions including business development. Ms. Fearn graduated from Warwick University with a BSc Honours degree in Chemistry and Medicinal Chemistry and is a member of The Organisation of Professionals in Regulatory Affairs (TOPRA).

Karen Frascello

Vice President, Business Development & Marketing, Global Access Programs

Karen has over 23 years of experience in the bio pharma industry, in a variety of commercial and strategic consulting roles. She started her career as a pharmaceutical sales representative and was promoted into increasing levels of responsibility eventually having oversight for a Pfizer primary care sales team and culminating as a Regional Sales Director for AstraZeneca’s respiratory portfolio.

After 10 years of leading sales teams to success, she transitioned into the role of Executive Director of Business Development for PDI, a leading US contract sales organization. In this position, she was responsible for developing innovative sales solutions for pharma which included building outsourced sales teams and enhancing sales using non-personal promotion strategies.

In 2010, Karen joined Idis, Inc. where she led the business development activities for global patient access and compassionate use programs, guiding top pharma and biotech companies through the strategic planning process and offering keen insight and recommendations for global access program development.

In her role as Vice President of Business Development and Marketing for Caligor Rx, she will leverage her knowledge and expertise of the global patient access environment to help pharma and biotech clients derive optimal solutions to provide unlicensed medicines to patients in a compliant and efficient manner. She will also lead the global marketing efforts for Caligor Rx as they continue to expand their robust service offerings for their pharmaceutical and biotech clients. Karen’s efforts will be supported by the experts within the CaligorRx regulatory and operational teams to ensure full compliance and controlled delivery of these important medicines into countries worldwide.

Karen graduated with honours and holds a BS in Biology from the University of Akron. She is also the Co-Chair of the Patient Access Committee for Global Genes/RARE Project, a leading rare disease advocacy organization for patients, caregivers and advocates.

Craig LaMarca

Craig LaMarca

Global Head of Business Development, TrialAssist

Craig joined CaligorRX in October of 2016 as Global Head of Business Development for the Trial Assist business unit. Craig’s background and training have a technical foundation with a BS in Pre-Veterinary Medicine, and a MS in Animal Sciences (endocrinology and cardiovascular disease). His first job out of graduate school was developing protein based assays utilized in pharmaceutical analytical development and product release. Craig has been in business development in various capacities for 10 years now with 8 years in the pharmaceutical services space. Having worked for various CDMOs (Cytovance, NextPharma and most recently PCI) involved with various aspects of the clinical development process, Craig has a sound understanding of what it takes to get a molecule to the market. Craig’s experience ranges from pre-clinical formulation development (biologics and small molecule) through clinical supply and commercial manufacturing including a variety of facets within that complex supply chain.